Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Pemetrexed in Combination With Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT01057589 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01057589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01057589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Pemetrexed in Combination With Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
October 31, 2012
Enrollment
66 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasms